Therefore, these results indicated that AEPE can alleviate CCl4-induced liver fibrosis by inhibiting the activation of HSCs and possibly through the TGF-β1/Smad signaling pathway. The gene discussed is TGFB1; the disease is Hepatic fibrosis.